Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	3.39B +1,042.1%
Revenue (ttm)	1.61B +47.5%
Net Income	517.39M +68.2%
EPS	22.74 -58.4%
Shares Out	22.75M
PE Ratio	6.55
Forward PE	n/a
Dividend	13.19 (8.88%)
Ex-Dividend Date	Oct 27, 2025

Volume	763,368
Average Volume	419,930
Open	148.50
Previous Close	148.50
Day's Range	146.03 - 155.00
52-Week Range	54.60 - 232.95
Beta	0.20
RSI	52.62
Earnings Date	Feb 9, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hypertensi...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In fiscal year 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.